The biosourced material is FDA-approved and compliant with EU food contact standards (EU 10/2011 – 1935/2004), making it ideal for application in the food and pharmaceutical industries.
The company is said to maintain one of the largest development labs for additive manufacturing in Europe, catering for prototyping and individual finished parts.
Solukon CEO Andreas Hartmann and Hélène Huby, CEO of the Exploration Company, in front of the Solukon SFM-AT350-E. The aerospace company is using 3D printing to support the production of flight ...